Friday, February 14, 2014

Newsletter 4.4: It's Valentines And Life Choice Has Natural Health Products For A Healthy Heart




The latest news from Life Choice!







February Alive Sale: Adrenal Capsules!

Life Choice is happy to pass Alive discounts on to our wholesale customers, but we ask that retailers would pass the savings on to retail customers, as well.

Learn more about our Adrenal capsules here.


Heart Health
With today being Valentine's Day, matters of the heart are on everyone's minds. However, for many, heart-related matters such as hypertension, angina, and heart disease/failure are ever-lurking concerns. Why not use Life Choice products to keep your heart in tip top shape?

Here are some suggestions:
  • L-Arginine: L-Arginine is great for heart health! The nitric oxide produced when Arginine metabolizes can help to regulate blood flow. One randomized, double-blind, placebo-controlled study of L-Arginine found that it increased blood flow, improved functional status, and improved arterial compliance significantly better than the placebo. Read the full study here. Similarly, a hypertension study involving pregnant female rats found that arginine supplementation significantly decreased blood pressure in rats with reduced uterine perfusion pressure. (Study here)
  • Adrenal Gland: The adrenal glands are very connected to heart health. In fact, a 2007 study found that targeting the adrenal glands during heart failure was beneficial. Gene therapy was used to shut down the adrenal gland's excessive output of fight or flight hormones such as epinephrine and norepinephrine. By blocking GRK2, an important regulatory enzyme, researchers cut the hormone production that forces the heart to pump too hard, leading to heart failure.
  • Migraine Relief: Carnitine and CoQ10 are huge heart helpers. In one study, 52 hemodialysis patients were given placebo, Carnitine, CoQ10, or both Carnitine and CoQ10. After 3 months of treatment, the non-placebo groups had a significant reduction of lipoprotein, which is a cardiovascular risk factor in hemodialysis patients. Based on a study of rat hearts, researchers stated that these elements combined were more effective than they were alone.
  • CLAW (coming soon): A JAMA study published last year researched the effects of chelation therapy on 1,708 patients aged 50 years or older who had experienced a myocardial infarction (MI) at least 6 weeks prior and had serum creatinine levels of 2.0 mg/dL or less. The study found that chelation therapy modestly reduced the risk of adverse cardiovascular outcomes. The scientists concluded that these results warrant further research into the potential of chelation.




Copyright © 2014 Life Choice, All rights reserved.

Our Contact Info is:
Address: P.O. Box 1696 Station Main, Cochrane, AB T4C 1B6
Tel: 866-226-1722
Fax: 866-226-1822
E-mail: info@life-choice.net
Web: www.life-choice.net


No comments:

Post a Comment